Literature DB >> 28242024

Enhancement of macrophage inflammatory responses by CCL2 is correlated with increased miR-9 expression and downregulation of the ERK1/2 phosphatase Dusp6.

William F Carson1, Sarah E Salter-Green2, Melissa M Scola3, Amrita Joshi4, Katherine A Gallagher5, Steven L Kunkel6.   

Abstract

Macrophage polarization plays a central role in both protective immunity and immunopathology. While the role of cytokines in driving macrophage polarization is well characterized, less is understood about the role of chemokines. The purpose of this study was to determine if CC chemokine 2 (CCL2/MCP1) could influence macrophage polarization in response to subsequent activation with cytokines and microbial products. Treatment of bone marrow-derived macrophages with CCL2 alone did not result in increased expression of either classical or alternatively-activated macrophage genes as compared to standard skewing cytokines or Toll-like receptor agonists. However, subsequent stimulation of CCL2 pre-treated macrophages with classical activation stimuli resulted in enhanced expression of genes associated with classical activation. This enhancement correlated with increased phosphorylation of ERK1/2 kinases, a decrease in expression of the ERK phosphatase Dusp6 and enhanced expression of miR-9. These results indicate that CCL2 supports the classical activation of macrophages, with miR-9 mediated down-regulation of Dusp6 and enhanced ERK-mediated signal transduction possibly mediating this enhanced pro-inflammatory gene expression.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chemokines; Gene regulation; Macrophages; Micro-RNA; Signal transduction

Mesh:

Substances:

Year:  2017        PMID: 28242024      PMCID: PMC5425952          DOI: 10.1016/j.cellimm.2017.02.005

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  34 in total

1.  Absence of CC chemokine ligand 2 results in an altered Th1/Th2 cytokine balance and failure to expel Trichuris muris infection.

Authors:  Matthew L deSchoolmeester; Matthew C Little; Barrett J Rollins; Kathryn J Else
Journal:  J Immunol       Date:  2003-05-01       Impact factor: 5.422

Review 2.  Macrophage plasticity and polarization: in vivo veritas.

Authors:  Antonio Sica; Alberto Mantovani
Journal:  J Clin Invest       Date:  2012-03-01       Impact factor: 14.808

Review 3.  DUSP meet immunology: dual specificity MAPK phosphatases in control of the inflammatory response.

Authors:  Roland Lang; Michael Hammer; Jörg Mages
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

4.  Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, Th cell expression, and IL-12 production.

Authors:  S W Chensue; K S Warmington; J H Ruth; P S Sanghi; P Lincoln; S L Kunkel
Journal:  J Immunol       Date:  1996-11-15       Impact factor: 5.422

5.  Local production of chemokines and prostaglandin E2 in the acute, chronic and recovery phase of murine experimental colitis.

Authors:  Silvia Melgar; Marketa Drmotova; Erika Rehnström; Liselotte Jansson; Erik Michaëlsson
Journal:  Cytokine       Date:  2006-11-07       Impact factor: 3.861

6.  Insulin regulation of MCP-1 in human adipose tissue of obese and lean women.

Authors:  Jukka Westerbacka; Anja Cornér; Maria Kolak; Janne Makkonen; Ursula Turpeinen; Anders Hamsten; Rachel M Fisher; Hannele Yki-Järvinen
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-02-12       Impact factor: 4.310

7.  CC chemokine receptor 4 modulates Toll-like receptor 9-mediated innate immunity and signaling.

Authors:  Makoto Ishii; Cory M Hogaboam; Amrita Joshi; Toshihiro Ito; Daniel J Fong; Steven L Kunkel
Journal:  Eur J Immunol       Date:  2008-08       Impact factor: 5.532

Review 8.  Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases.

Authors:  Shambhunath Bose; Jungsook Cho
Journal:  Arch Pharm Res       Date:  2013-06-15       Impact factor: 4.946

9.  Phenotypic characterization of lung macrophages in asthmatic patients: overexpression of CCL17.

Authors:  Karl J Staples; Timothy S C Hinks; Jon A Ward; Victoria Gunn; Caroline Smith; Ratko Djukanović
Journal:  J Allergy Clin Immunol       Date:  2012-09-14       Impact factor: 10.793

10.  Mammalian N-glycan branching protects against innate immune self-recognition and inflammation in autoimmune disease pathogenesis.

Authors:  Ryan S Green; Erica L Stone; Mari Tenno; Eero Lehtonen; Marilyn G Farquhar; Jamey D Marth
Journal:  Immunity       Date:  2007-08-02       Impact factor: 31.745

View more
  19 in total

1.  The CCL2/CCR2 axis is critical to recruiting macrophages into acellular nerve allograft bridging a nerve gap to promote angiogenesis and regeneration.

Authors:  Deng Pan; Jesús A Acevedo-Cintrón; Junichi Sayanagi; Alison K Snyder-Warwick; Susan E Mackinnon; Matthew D Wood
Journal:  Exp Neurol       Date:  2020-05-23       Impact factor: 5.330

Review 2.  Macrophage polarization and allergic asthma.

Authors:  Arjun Saradna; Danh C Do; Shruthi Kumar; Qing-Ling Fu; Peisong Gao
Journal:  Transl Res       Date:  2017-10-07       Impact factor: 7.012

3.  miR-9 and miR-263 Regulate the Key Genes of the ERK Pathway in the Ovary of Mud Crab Scylla paramamosain.

Authors:  Mingcan Zhou; Xiwei Jia; Haifu Wan; Shuhong Wang; Xin Zhang; Ziping Zhang; Yilei Wang
Journal:  Mar Biotechnol (NY)       Date:  2020-07-11       Impact factor: 3.619

4.  Phagocytosis of Leptospira by leukocytes from mice with different susceptibility to leptospirosis and possible role of chemokines.

Authors:  Paloma L da Silva; Fabiana Lauretti-Ferreira; Maiara Caldas de Lima; Swiany Silveira Lima; Ambart E Covarrubias; Marcelo De Franco; Eneas Carvalho; Paulo Lee Ho; Renata M A da Costa; Elizabeth A L Martins; Josefa B Da Silva
Journal:  BMC Microbiol       Date:  2019-01-07       Impact factor: 3.605

5.  IFN Regulatory Factor 4 Controls Post-ischemic Inflammation and Prevents Chronic Kidney Disease.

Authors:  Georg Lorenz; Foteini Moschovaki-Filippidou; Vivian Würf; Philipp Metzger; Stefanie Steiger; Falk Batz; Javier Carbajo-Lozoya; Joanna Koziel; Max Schnurr; Clemens D Cohen; Christoph Schmaderer; Hans-Joachim Anders; Maja Lindenmeyer; Maciej Lech
Journal:  Front Immunol       Date:  2019-10-01       Impact factor: 7.561

6.  Inhibition of SIRT1 by microRNA-9, the key point in process of LPS-induced severe inflammation.

Authors:  Mengyuan Cao; Wanfu Zhang; Junjie Li; Julei Zhang; Lincheng Li; Mingchuan Liu; Wen Yin; Xiaozhi Bai
Journal:  Arch Biochem Biophys       Date:  2018-12-13       Impact factor: 4.013

7.  Translational control of ERK signaling through miRNA/4EHP-directed silencing.

Authors:  Seyed Mehdi Jafarnejad; Clément Chapat; Edna Matta-Camacho; Idit Anna Gelbart; Geoffrey G Hesketh; Meztli Arguello; Aitor Garzia; Sung-Hoon Kim; Jan Attig; Maayan Shapiro; Masahiro Morita; Arkady Khoutorsky; Tommy Alain; Christos G Gkogkas; Noam Stern-Ginossar; Thomas Tuschl; Anne-Claude Gingras; Thomas F Duchaine; Nahum Sonenberg
Journal:  Elife       Date:  2018-02-07       Impact factor: 8.140

8.  Cholangiocyte-Derived Exosomal lncRNA H19 Promotes Macrophage Activation and Hepatic Inflammation under Cholestatic Conditions.

Authors:  Xiaojiaoyang Li; Runping Liu; Yanyan Wang; Weiwei Zhu; Derrick Zhao; Xuan Wang; Hang Yang; Emily C Gurley; Weidong Chen; Phillip B Hylemon; Huiping Zhou
Journal:  Cells       Date:  2020-01-11       Impact factor: 7.666

9.  Phase I dose-escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer.

Authors:  Takaaki Masuda; Miwa Noda; Takahiro Kogawa; Dai Kitagawa; Naoki Hayashi; Takahito Jomori; Yoichi Nakanishi; Keiichi I Nakayama; Shinji Ohno; Koshi Mimori
Journal:  Cancer Sci       Date:  2020-02-11       Impact factor: 6.716

10.  Astroglial TLR9 antagonism promotes chemotaxis and alternative activation of macrophages via modulation of astrocyte-derived signals: implications for spinal cord injury.

Authors:  Lun Li; Li Ni; Robert F Heary; Stella Elkabes
Journal:  J Neuroinflammation       Date:  2020-02-25       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.